AKAN Stock Analysis: Buy, Sell, or Hold?
AKAN - Akanda Corp. Common Shares
$1.20
-0.08 (-6.25%)
▼
5d:
-33.7%
30d:
+162.41%
90d:
-25.47%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Get Alerted When AKAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called AKAN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AKAN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AKAN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AKAN is currently trading at $1.20, which is considered slightly high relative to its 30-day fair value range of $0.40 to $1.65.
Technical Outlook: Technically, AKAN is in a strong downtrend. The price is currently testing key support at $1.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AKAN is in a strong downtrend. The price is currently testing key support at $1.22. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$0.40 -
$1.65
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.3%)
- CAUTION: 5-day price weakness (-33.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.40 -
$1.65
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.22
Resistance Level
$2.25
Current Trend
Strong Downtrend
Fundamental Context
Revenue Growth (YoY)
21.9%
Profit Margin
-266.3%
Last updated: February 02, 2026 1:22 PM ET
Data refreshes hourly during market hours. Next update: 2:22 PM
Data refreshes hourly during market hours. Next update: 2:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 60 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 54 HOLD |
